Alpha-GPC: Difference between revisions
Jump to navigation
Jump to search
m Protected "Alpha-GPC": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Overview== | ==Overview== | ||
| Line 8: | Line 8: | ||
== References == | == References == | ||
{{reflist|2}} | |||
==See also== | ==See also== | ||
Latest revision as of 14:16, 4 September 2012
Overview
L-Alpha Glycerylphosphorylcholine (Alpha GPC) is a naturally occurring phospholipid precursor and metabolite. Alpha GPC delivers choline to the brain across the blood-brain barrier.
Studies have investigated its efficacy for cognitive disorders including stroke and Alzheimer’s Disease. An Italian multicentre clinical trial on 2,044 patients suffering from recent stroke were supplied alpha-GPC in doses of 1,000 mg/day for 28 days and 400 mg/day for five ensuing months. The trial confirmed the therapeutic role of alpha-GPC on the cognitive recovery of patients based on four measurement scales, three of which reached statistical significance.[1]
References
- ↑ Barbagallo Sangiorgi G, et al. "Alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks." An Italian multicenter clinical trial. Ann NY Acad Sci 1994; 717:253-69.